logo

For the Inventor, By the Inventor

Wokingham, United Kingdom

Roger John Gillespie

USPTO Granted Patents = 25 



Average Co-Inventor Count = 3.6

ph-index = 9

Forward Citations = 218(Granted Patents)


Location History:

  • Berkshire, GB (2001)
  • Wilts, GB (2002)
  • Wokingham, GB (2003 - 2011)
  • Winnersh, GB (2004 - 2022)

Company Filing History:

goldMedal16 out of 43 
 
Vernalis Research Limited
 patents
silverMedal9 out of 68 
 
Vernalis &r&d) Ltd.
 patents

Years Active: 2001-2022

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents
1. 11466019 - Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists (2022-10-11),
2. 10875868 - Triazolo[4,5-d] pyramidine derivatives and their use as purine receptor antagonists (2020-12-29),
3. 10538526 - Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists (2020-01-21),
4. 10106547 - Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists (2018-10-23),
5. 9765080 - Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists (2017-09-19),
6. 9376443 - Triazolo[4,5-D] pyramidine derivatives and their use as purine receptor antagonists (2016-06-28),
7. 8987279 - Triazolo [4, 5-D] pyramidine derivatives and their use as purine receptor antagonists (2015-03-24),
8. 8450328 - Triazolo[4,5-D]pyramidine derivatives and their use as purine receptor antagonists (2013-05-28),
9. 7875600 - Pyrimidine compounds as purine receptor antagonist (2011-01-25),
10. 7629349 - Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists (2009-12-08),
11. 7598256 - Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists (2009-10-06),
12. 7589097 - Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists (2009-09-15),
13. 7452894 - Purine derivatives as purinergic receptor antagonists (2008-11-18),
14. 7405219 - Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists (2008-07-29),
15. 7384949 - Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists (2008-06-10),

Title: The Innovative Journey of Roger John Gillespie

Introduction: Roger John Gillespie, a pioneering inventor hailing from Wokingham, GB, has made significant contributions to the field of technology through his inventive spirit and dedication to progress.

Latest Patents: Roger John Gillespie's latest patents showcase his commitment to innovation and problem-solving in various industries, ranging from electronics to sustainable energy solutions.

Career Highlights: With a career spanning over two decades, Roger John Gillespie has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing groundbreaking solutions to address them.

Collaborations: Throughout his career, Roger John Gillespie has collaborated with leading research institutions, universities, and forward-thinking companies to bring his inventions to life and make a lasting impact on the world.

Conclusion: Roger John Gillespie's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, solidifies his position as a trailblazing inventor whose work continues to shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…